Published On: Wed, Oct 19th, 2016

Latest Analyst Reports On ICU Medical, Inc.


Recently stock market analysts have updated their consensus ratings on shares of ICU Medical, Inc. (NASDAQ:ICUI).

Most recent broker ratings

08/09/2016 – ICU Medical, Inc. had its “neutral” rating reiterated by analysts at Piper Jaffray. They now have a USD 119 price target on the stock.

03/11/2016 – ICU Medical, Inc. had its “buy” rating reiterated by analysts at Gabelli. They now have a USD 128 price target on the stock.

12/16/2015 – ICU Medical, Inc. had its “buy” rating reiterated by analysts at Roth Capital.

09/30/2014 – ICU Medical, Inc. was upgraded to “strong-buy” by analysts at Raymond James. They now have a USD 77 price target on the stock.

09/23/2014 – ICU Medical, Inc. was upgraded to “outperform” by analysts at CJS Securities. They now have a USD 80 price target on the stock.

08/14/2014 – ICU Medical, Inc. was upgraded to “outperform” by analysts at Zacks. They now have a USD 66.9 price target on the stock.

05/08/2014 – ICU Medical, Inc. was downgraded to “hold” by analysts at TheStreet.

10/29/2013 – ICU Medical, Inc. was upgraded to “buy” by analysts at Jefferson Research.

ICU Medical, Inc. has a 50 day moving average of 130.70 and a 200 day moving average of 114.79. The stock’s market capitalization is 2.32B, it has a 52-week low of 85.56 and a 52-week high of 152.69.

The share price of the company (NASDAQ:ICUI) was down -1.23%, with a high of 149.49 during the day and the volume of ICU Medical, Inc. shares traded was 269529.

ICU Medical, Inc. is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. It operates through the segment, which is engaged in the development, manufacturing and sale of medical technologies used in infusion therapy, critical care and oncology applications. Its Infusion Therapy products include MicroClave and MicroClave Clear, Neutron, NanoClave, Clave and SwabCap. Its Critical Care products include Hemodynamic Monitoring Systems, Closed Blood Sampling and Conservation Systems, and Other Critical Care Products and Accessories. Its Oncology products include ChemoLock CSTD and components, ChemoClave CSTD and components and Diana hazardous drug compounding system.